Cite

HARVARD Citation

    Wurstbauer, K. et al. (n.d.). EP-1350 DART-bid by VMAT for locally advanced NSCLC: Low toxicity, encouraging survival and tumor control. Radiotherapy and oncology. pp. S738-S739. [Online]. 
  
Back to record